Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Quick Ratio deteriorated to 3.76 below Science 37 Holdings Inc 's average Quick Ratio.

Within Medical Laboratories industry 12 other companies have achieved higher Quick Ratio than Science 37 Holdings Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 742 to 865.

Explain Quick Ratio?
How much Cash & cash equivalents SNCE�s has?
What are SNCE�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SNCE Quick Ratio	(Sep 30 2023) Q3	(Jun 30 2023) Q2	(Mar 31 2023) Q1	(Dec 31 2022) Q4	(Sep 30 2022) Q3
Y / Y Current Liabilities Change	-18.74 %	-23.78 %	-42.18 %	-36.98 %	2486.76 %
Y / Y Cash & cash equivalent Change	-56.69 %	-56.18 %	-53.97 %	-49.63 %	64728.74 %
Quick Ratio MRQ	3.76	4.07	5.62	5.69	7.05
SNCE's Total Ranking	# 865	# 742	# 604	# 546	#
Seq. Current Liabilities Change	-5.87 %	8.47 %	-22.53 %	2.73 %	-11.71 %
Seq. Cash & cash equivalent Change	-13.22 %	-21.35 %	-23.54 %	-17.01 %	-12.2 %

Quick Ratio third quarter 2023 Company Ranking
Within:	No.
Medical Laboratories Industry	# 13
Healthcare Sector	# 446
Overall Market	# 865

Quick Ratio Statistics
High	Average	Low
8.15	5.14	0.28
(Mar 31 2021)		(Sep 30 2021)

Financial Statements
Science 37 Holdings Inc 's Current Liabilities	$ 15 Millions	Visit SNCE's Balance sheet
Science 37 Holdings Inc 's Cash & cash equivalent	$ 56 Millions	Visit SNCE's Balance sheet
Source of SNCE's Sales		Visit SNCE's Sales by Geography

Cumulative Science 37 Holdings Inc 's Quick Ratio

SNCE's Quick Ratio for the trailling 12 Months

SNCE Quick Ratio	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months
Y / Y Current Liabilities TTM Growth	-31.92 %	-11.76 %	29.6 %	169.91 %	10052.23 %
Y / Y Cash & cash equivalent TTM Growth	-53.6 %	-28.88 %	18.88 %	162.2 %	1888.89 %
Quick Ratio TTM	4.83	5.66	6.42	6.75	7.08
Total Ranking TTM	# 3622	# 3551	# 3528	# 248	#
Seq. Current Liabilities TTM Growth	-5.08 %	-6.81 %	-12.8 %	-11.73 %	23.01 %
Seq. Cash & cash equivalent TTM Growth	-19.13 %	-17.76 %	-17.12 %	-15.83 %	23.96 %

Quick ratio ranking by company, industry and sector >> Back to SNCE Financial Strength Comparisons >> Go to Compare SNCE Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in SNCE's Current Liabilities to $15.02 millions, cumulative Quick Ratio to 4.83 below the SNCE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 43 other companies have achieved higher Quick Ratio than Science 37 Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3551 to 3622.

Explain Quick Ratio?
How much Cash & cash equivalents SNCE�s has?
What are SNCE�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 44
Healthcare Sector	# 1033
Within the Market	# 3622

trailing twelve months Quick Ratio Statistics
High	Average	Low
5.69	5.32	4.32
(Mar 31 2022)		(Sep 30 2023)

Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Laboratories Industry	Quick Ratio	Sep 30 2023 MRQ Cash & cash equivalent	Sep 30 2023 MRQ Current Liabilities
Viridian Therapeutics Inc	8.77	$ 201.410 Millions	$ 22.959 Millions
Omniab Inc	6.79	$ 96.628 Millions	$ 14.226 Millions
Castle Biosciences Inc	6.33	$ 229.753 Millions	$ 36.324 Millions
Butterfly Network Inc	6.21	$ 150.006 Millions	$ 24.147 Millions
Nano X Imaging Ltd	5.62	$ 82.383 Millions	$ 14.663 Millions
Dermtech Inc	5.40	$ 68.200 Millions	$ 12.636 Millions
Guardant Health Inc	5.09	$ 1,154.821 Millions	$ 226.751 Millions
Veracyte Inc	4.05	$ 202.463 Millions	$ 50.039 Millions
Bionexus Gene Lab Corp	3.82	$ 6.147 Millions	$ 1.610 Millions
Science 37 Holdings Inc	3.76	$ 56.407 Millions	$ 15.020 Millions
Personalis Inc	3.72	$ 120.663 Millions	$ 32.478 Millions
Caredx Inc	3.69	$ 268.184 Millions	$ 72.674 Millions
Sera Prognostics Inc	3.40	$ 46.116 Millions	$ 13.545 Millions
Exagen Inc	3.17	$ 28.448 Millions	$ 8.981 Millions
Incyte Corporation	3.13	$ 3,516.453 Millions	$ 1,124.680 Millions
WEED, INC.	3.00	$ 0.644 Millions	$ 0.215 Millions
Hologic Inc	2.91	$ 2,722.500 Millions	$ 934.400 Millions
Absci Corp	2.81	$ 69.733 Millions	$ 24.799 Millions
Burning Rock Biotech Limited	2.43	$ 86.634 Millions	$ 35.710 Millions
Bioaffinity Technologies Inc	2.30	$ 4.509 Millions	$ 1.959 Millions
Exact Sciences Corporation	1.65	$ 734.406 Millions	$ 446.124 Millions
Ispecimen inc	1.61	$ 5.663 Millions	$ 3.517 Millions
Invitae Corporation	1.61	$ 254.573 Millions	$ 158.419 Millions
American Shared Hospital Services	1.46	$ 14.655 Millions	$ 10.049 Millions
Fulgent Genetics Inc	1.37	$ 84.076 Millions	$ 61.421 Millions
Natera Inc	1.06	$ 267.847 Millions	$ 251.705 Millions
Radnet Inc	0.96	$ 392.362 Millions	$ 407.077 Millions
Renalytix Plc	0.92	$ 13.891 Millions	$ 15.173 Millions

Date modified: 2026-08-31T19:27:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.